Paper41314850
Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study.
Chen Y and 15 others. BMJ Open, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study. Papers, record 41314850. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41314850
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Association between periprocedural change in serum renalase and microvascular obstruction in patients with STEMI after primary percutaneous coronary intervention: protocol for the ReMVOS prospective cohort study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Percutaneous Coronary Intervention | Major topic |
| ST Elevation Myocardial Infarction | Major topic |
| Postoperative Complications | Major topic |
| Humans | |
| Prospective Studies | |
| Biomarkers | |
| Microcirculation | |
| Male | |
| Female | |
| Middle Aged | |
| China | |
| Observational Studies as Topic | |
| Monoamine Oxidase |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06669520 | Correlation of Blood Serum Renalase and Microcirculation Obstruction in Patients with Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention | Derived from the trial | Yes |
Source ClinicalTrials.gov
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33624185 | Predictors of Microvascular Reperfusion After Myocardial Infarction. | Curr Cardiol Rep | 2021 | https://conductscience.org/library/papers/33624185 | PubMed |
| 2 | 35586740 | Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. | Glob Heart | 2022 | https://conductscience.org/library/papers/35586740 | PubMed |
| 3 | 30630613 | Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia. | Int J Cardiol | 2019 | https://conductscience.org/library/papers/30630613 | PubMed |
| 4 | 38583174 | Visual Estimates of Coronary Slow Flow Are Not Associated With Invasive Wire-Based Diagnoses of Coronary Microvascular Dysfunction. | Circ Cardiovasc Interv | 2024 | https://conductscience.org/library/papers/38583174 | PubMed |
| 5 | 38283173 | Utility of electrocardiogram to predict the occurrence of the no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PPCI): a systematic review and meta-analysis. | Front Cardiovasc Med | 2023 | https://conductscience.org/library/papers/38283173 | PubMed |
| 6 | 40835783 | External Comparator Studies: Performance of Four Missing Data-Handling Approaches, Stratified by Four Different Marginal Estimators. | Drug Saf | 2025 | https://conductscience.org/library/papers/40835783 | PubMed |
| 7 | 31617010 | Coronary microvascular obstruction: the new frontier in cardioprotection. | Basic Res Cardiol | 2019 | https://conductscience.org/library/papers/31617010 | PubMed |
| 8 | 38400562 | The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis. | Clin Cardiol | 2024 | https://conductscience.org/library/papers/38400562 | PubMed |
| 9 | 29020248 | Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials. | Eur Heart J | 2017 | https://conductscience.org/library/papers/29020248 | PubMed |
| 10 | 25497549 | Renalase is a novel target gene of hypoxia-inducible factor-1 in protection against cardiac ischaemia-reperfusion injury. | Cardiovasc Res | 2015 | https://conductscience.org/library/papers/25497549 | PubMed |
| 11 | 15881532 | Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. | J Cardiovasc Magn Reson | 2005 | https://conductscience.org/library/papers/15881532 | PubMed |
| 12 | 40622620 | Predicting MRI-diagnosed microvascular obstruction and its long-term impact after acute myocardial infarction. | Clin Res Cardiol | 2025 | https://conductscience.org/library/papers/40622620 | PubMed |
| 13 | 30032783 | Research Techniques Made Simple: Sample Size Estimation and Power Calculation. | J Invest Dermatol | 2018 | https://conductscience.org/library/papers/30032783 | PubMed |
| 14 | 15841207 | Renalase is a novel, soluble monoamine oxidase that regulates cardiac function and blood pressure. | J Clin Invest | 2005 | https://conductscience.org/library/papers/15841207 | PubMed |
| 15 | 37052556 | Impact of Persistent Microvascular Obstruction Late After STEMI on Adverse LV Remodeling: A CMR Study. | JACC Cardiovasc Imaging | 2023 | https://conductscience.org/library/papers/37052556 | PubMed |
| 16 | 32689822 | Redefining Adverse and Reverse Left Ventricular Remodeling by Cardiovascular Magnetic Resonance Following ST-Segment-Elevation Myocardial Infarction and Their Implications on Long-Term Prognosis. | Circ Cardiovasc Imaging | 2020 | https://conductscience.org/library/papers/32689822 | PubMed |
| 17 | 9737521 | Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. | Circulation | 1998 | https://conductscience.org/library/papers/9737521 | PubMed |
| 18 | 18299506 | Catecholamines regulate the activity, secretion, and synthesis of renalase. | Circulation | 2008 | https://conductscience.org/library/papers/18299506 | PubMed |
| 19 | 25966766 | Renalase protects the cardiomyocytes of Sprague-Dawley rats against ischemia and reperfusion injury by reducing myocardial cell necrosis and apoptosis. | Kidney Blood Press Res | 2015 | https://conductscience.org/library/papers/25966766 | PubMed |
| 20 | 32916539 | Roles and mechanisms of renalase in cardiovascular disease: A promising therapeutic target. | Biomed Pharmacother | 2020 | https://conductscience.org/library/papers/32916539 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RNLS | 55328 | PubTator's text mining | https://conductscience.org/library/genes/55328 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41314850
GET https://conductscience.org/api/papers/v1/41314850/references?page=2